Report Detail
Global Long-acting Anti-HIV Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4673909 |
- 18 February, 2026 |
- Global |
- 99 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Long-acting Anti-HIV Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Long-acting anti-HIV drugs provide effective treatment options for HIV-infected people and have been widely recognized by the market. With the continuous deepening of research and development and the growth of market demand, long-acting anti-HIV drugs are expected to play a greater role in the future.
This report is a detailed and comprehensive analysis for global Long-acting Anti-HIV Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting Anti-HIV Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Long-acting Anti-HIV Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Long-acting Anti-HIV Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Long-acting Anti-HIV Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long-acting Anti-HIV Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long-acting Anti-HIV Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead, ViiV Healthcare, Janssen, Tibotec, Cipla, Frontier Biopharmaceutical (Nanjing) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting Anti-HIV Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CAB Long-acting Injection
RPV Long-acting Injection
Market segment by Application
Hospital
Clinic
Others
Major players covered
Gilead
ViiV Healthcare
Janssen
Tibotec
Cipla
Frontier Biopharmaceutical (Nanjing) Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-acting Anti-HIV Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting Anti-HIV Drug, with price, sales quantity, revenue, and global market share of Long-acting Anti-HIV Drug from 2021 to 2026.
Chapter 3, the Long-acting Anti-HIV Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting Anti-HIV Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Long-acting Anti-HIV Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Anti-HIV Drug.
Chapter 14 and 15, to describe Long-acting Anti-HIV Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Long-acting Anti-HIV Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 CAB Long-acting Injection
- 1.3.3 RPV Long-acting Injection
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Long-acting Anti-HIV Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Long-acting Anti-HIV Drug Market Size & Forecast
- 1.5.1 Global Long-acting Anti-HIV Drug Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Long-acting Anti-HIV Drug Sales Quantity (2021-2032)
- 1.5.3 Global Long-acting Anti-HIV Drug Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Gilead
- 2.1.1 Gilead Details
- 2.1.2 Gilead Major Business
- 2.1.3 Gilead Long-acting Anti-HIV Drug Product and Services
- 2.1.4 Gilead Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Gilead Recent Developments/Updates
- 2.2 ViiV Healthcare
- 2.2.1 ViiV Healthcare Details
- 2.2.2 ViiV Healthcare Major Business
- 2.2.3 ViiV Healthcare Long-acting Anti-HIV Drug Product and Services
- 2.2.4 ViiV Healthcare Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 ViiV Healthcare Recent Developments/Updates
- 2.3 Janssen
- 2.3.1 Janssen Details
- 2.3.2 Janssen Major Business
- 2.3.3 Janssen Long-acting Anti-HIV Drug Product and Services
- 2.3.4 Janssen Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Janssen Recent Developments/Updates
- 2.4 Tibotec
- 2.4.1 Tibotec Details
- 2.4.2 Tibotec Major Business
- 2.4.3 Tibotec Long-acting Anti-HIV Drug Product and Services
- 2.4.4 Tibotec Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Tibotec Recent Developments/Updates
- 2.5 Cipla
- 2.5.1 Cipla Details
- 2.5.2 Cipla Major Business
- 2.5.3 Cipla Long-acting Anti-HIV Drug Product and Services
- 2.5.4 Cipla Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Cipla Recent Developments/Updates
- 2.6 Frontier Biopharmaceutical (Nanjing) Co., Ltd.
- 2.6.1 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Details
- 2.6.2 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Major Business
- 2.6.3 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product and Services
- 2.6.4 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Long-acting Anti-HIV Drug by Manufacturer
- 3.1 Global Long-acting Anti-HIV Drug Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Long-acting Anti-HIV Drug Revenue by Manufacturer (2021-2026)
- 3.3 Global Long-acting Anti-HIV Drug Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Long-acting Anti-HIV Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Long-acting Anti-HIV Drug Manufacturer Market Share in 2025
- 3.4.3 Top 6 Long-acting Anti-HIV Drug Manufacturer Market Share in 2025
- 3.5 Long-acting Anti-HIV Drug Market: Overall Company Footprint Analysis
- 3.5.1 Long-acting Anti-HIV Drug Market: Region Footprint
- 3.5.2 Long-acting Anti-HIV Drug Market: Company Product Type Footprint
- 3.5.3 Long-acting Anti-HIV Drug Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Long-acting Anti-HIV Drug Market Size by Region
- 4.1.1 Global Long-acting Anti-HIV Drug Sales Quantity by Region (2021-2032)
- 4.1.2 Global Long-acting Anti-HIV Drug Consumption Value by Region (2021-2032)
- 4.1.3 Global Long-acting Anti-HIV Drug Average Price by Region (2021-2032)
- 4.2 North America Long-acting Anti-HIV Drug Consumption Value (2021-2032)
- 4.3 Europe Long-acting Anti-HIV Drug Consumption Value (2021-2032)
- 4.4 Asia-Pacific Long-acting Anti-HIV Drug Consumption Value (2021-2032)
- 4.5 South America Long-acting Anti-HIV Drug Consumption Value (2021-2032)
- 4.6 Middle East & Africa Long-acting Anti-HIV Drug Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 5.2 Global Long-acting Anti-HIV Drug Consumption Value by Type (2021-2032)
- 5.3 Global Long-acting Anti-HIV Drug Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 6.2 Global Long-acting Anti-HIV Drug Consumption Value by Application (2021-2032)
- 6.3 Global Long-acting Anti-HIV Drug Average Price by Application (2021-2032)
7 North America
- 7.1 North America Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 7.2 North America Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 7.3 North America Long-acting Anti-HIV Drug Market Size by Country
- 7.3.1 North America Long-acting Anti-HIV Drug Sales Quantity by Country (2021-2032)
- 7.3.2 North America Long-acting Anti-HIV Drug Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 8.2 Europe Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 8.3 Europe Long-acting Anti-HIV Drug Market Size by Country
- 8.3.1 Europe Long-acting Anti-HIV Drug Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Long-acting Anti-HIV Drug Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Long-acting Anti-HIV Drug Market Size by Region
- 9.3.1 Asia-Pacific Long-acting Anti-HIV Drug Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Long-acting Anti-HIV Drug Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 10.2 South America Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 10.3 South America Long-acting Anti-HIV Drug Market Size by Country
- 10.3.1 South America Long-acting Anti-HIV Drug Sales Quantity by Country (2021-2032)
- 10.3.2 South America Long-acting Anti-HIV Drug Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Long-acting Anti-HIV Drug Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Long-acting Anti-HIV Drug Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Long-acting Anti-HIV Drug Market Size by Country
- 11.3.1 Middle East & Africa Long-acting Anti-HIV Drug Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Long-acting Anti-HIV Drug Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Long-acting Anti-HIV Drug Market Drivers
- 12.2 Long-acting Anti-HIV Drug Market Restraints
- 12.3 Long-acting Anti-HIV Drug Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Long-acting Anti-HIV Drug and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Long-acting Anti-HIV Drug
- 13.3 Long-acting Anti-HIV Drug Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Long-acting Anti-HIV Drug Typical Distributors
- 14.3 Long-acting Anti-HIV Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Long-acting Anti-HIV Drug. Industry analysis & Market Report on Long-acting Anti-HIV Drug is a syndicated market report, published as Global Long-acting Anti-HIV Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Long-acting Anti-HIV Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
